May 6, 2020 / 12:31 PM / 25 days ago

BRIEF-AB Science Granted Authorization By ANSM To Initiate Phase 2 Study Evaluating Masitinib In Combination With Isoquercetin For The Treatment Of Covid-19

May 6 (Reuters) - AB Science SA:

* AB SCIENCE GRANTED AUTHORIZATION BY ANSM TO INITIATE PHASE 2 STUDY EVALUATING MASITINIB IN COMBINATION WITH ISOQUERCETIN FOR THE TREATMENT OF COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below